Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease: a meta-analysis of CKD progression trials

Clin J Am Soc Nephrol. 2024 Apr 16. doi: 10.2215/CJN.0000000000000470. Online ahead of print.NO ABSTRACTPMID:38622766 | DOI:10.2215/CJN.0000000000000470

Source: Clinical Journal of the American Society of Nephrology : CJASN - April 16, 2024 Category: Urology & Nephrology Authors: Robert A Fletcher William G Herrington Rajiv Agarwal Kaitlin J Mayne Clare Arnott Meg J Jardine Kenneth W Mahaffey Vlado Perkovic Natalie Staplin David C Wheeler Glenn M Chertow Hiddo J L Heerspink Brendon L Neuen Source Type: research